Table 1.
Serum and Cerebrospinal fluid results
| Result | Reference range | |
|---|---|---|
| Hemoglobin (g/dL) | 10.2 | 11.5-15.1 |
| White cell count (K/uL) | 4.5 | 3.5-10.6 |
| Na (mEq/L) | 137 | 136-145 |
| Vitamin B12 (pg/mL) | 548 | 180-914 |
| Vitamin E alpha (mg/L) | 11.4 | 5.9-19.4 |
| TSH (mU/L) | 0.94 | 0.45-5.1 |
| ACE | 36.2 | 8-52 |
| Lyme antibody screen | 0.1 | <0.9 |
| CSF | ||
| Glucose (mg/dL) | 69 | 40-70 |
| Protein (mg/dL) | 30 | 15-45 |
| WBC/cu mm | 95 with 98% lymphocytes | 0-5 |
| Oligoclonal bands | 2 | 0-2 |
| IgG index | 0.52 | 0-0.85 |
| Infectious panel (EBV, CMV, HHV6, VZV, West Nile Virus, Enterovirus) in the serum | Negative | Negative |
| Infectious panel (EBV, CMV, HHV6, VZV, West Nile Virus, Enterovirus) in the CSF | Negative | Negative |
| Paraneoplastic panels (ANNA-1, 2, 3; AGNA-1; CRMP-5; PCA-1, 2, Tr; amphiphysin) in the serum | Negative | Negative |
| Paraneoplastic panels (ANNA-1, 2, 3; AGNA-1; CRMP-5; PCA-1, 2, Tr; amphiphysin) in the CSF | Negative | Negative |
| Autoimmune panel | ||
| AQP-4 IgG of in serum | 1:100000 | <1:5 |
| AQP-4 IgG of in CSF | 1:256 | <1:5 |
| SSA (AAU/mL) | 117.9 | 0-24.9 |
| SSB (AAU/mL) | 97.5 | 0-24.9 |
| ANA | 1:1280 | <1:40 |
| dsDNA (IU/mL) | Negative | Negative |
| Complement C3 (mg/dL) | 102 | 86-184 |
| Complement C4 (mg/dL) | 29 | 20-58 |
| MOG antibody | Negative | Negative |
| Anti-Jo1, anti-RNP, SCL70, anti-SM, Rheumatoid factor, and anticardiolipin antibody | Negative | 0-24.9 |
Abbreviations: Na, sodium; TSH, thyroid-stimulating hormone; ACE, angiotensin converting enzyme; CSF, cerebrospinal fluid; WBCs, white blood cells; EBV, Epstein Barr virus; CMV, cytomegalovirus; HHV6, human herpes virus 6; VZV, varicella zoster virus; ANNA-1, anti-neuronal nuclear antibody type 1; ANNA-2, anti-neuronal nuclear antibody type 2; ANNA-3, anti-neuronal nuclear antibody type 3; AGNA-1, anti-glial nuclear antibody type 1; CRMP-5, collapsin-response-mediator protein-5; PCA, Purkinje cell cytoplasmic autoantibody; AQP-4 IgG, aquaporin 4 antibodies; SSA, anti-Sjogren syndrome type A; SSB, anti-Sjogren syndrome type B; ANA, antinuclear antibody; dsDNA, anti-double stranded DNA antibody; anti-Jo1, anti-histidyl-tRNA synthetase; anti-RMP, antinuclear ribonucleoprotein; SCL70, topoisomerase 1; anti-SM, anti-Smith antibody; MOG, myelin oligodendrocyte glycoprotein.